Blog by Faith Otewa In my role as site coordinator of the Kisumu Center office, I’ve had the opportunity to oversee the “Hybrid Study,” in which we are looking at integrating HPV testing into community health campaigns providing multiple other disease services, including HIV testing, family planning and TB testing.  Many of the experiences will linger on with us for many years to come; while some illustrate the challenges encountered in conducting research and community-based care in Africa, others show the power of community mobilization and knowledge. It is the 10th week out in the field and the study team are getting ready to recruit at the 3rd set of campaigns. However, as if often the case in western Kenya, and certainly when we are working in tents set out in the middle of fields, the climate has had a big impact on study.  The harsh weather and copious rainstorms experienced in the month of May this vastly affected recruitment. There has...

By Moreen Njoroge, T-19 Cervical cancer is the second most common cancer in women worldwide and the most common cancer among women in sub-Saharan Africa. The risk for cervical pre-cancer and cancer is increased by the biological effects of co-infection with HIV and HPV, both of which have a higher prevalence in sub-Saharan Africa and especially in Migori, Kenya where the seroprevalence of HIV/AIDS is not uncommon. The social and economic factors in Migori, Kenya make cervical cancer control more difficult to achieve with the established standard of care in developed countries. A major barrier to accessing screening and treatment services for cervical cancer in this region is poor health literacy associated with the lower educational-attainment rates in Kenya, especially for women. Structural barriers associated with increased cervical cancer mortality rates include lack of diagnostic tools for screening, understaffing in clinics and hospitals, a paucity of pathology laboratories and the long waiting times associated with screening-result transmission. The lack of treatment...

On Friday, October 20th, public health professionals from around the Triangle gathered at Duke to discuss how best to advance women’s health in the current political environment. Keynote speeches were given by Jen Kates, Vice President and Director of Global HIV Policy at the Kaiser Family Foundation, and North Carolina Congressman David Price. Women’s health right now is in an era of uncertainty. Jen Kates focused on this as she outlined many of the questions that remain regarding how the Trump administration will implement many of its proposed changes to global health policy. Unfortunately, this uncertainty extends to women’s health domestically as well. Congressman David Price described expected and potential changes to the Affordable Care Act and the devastating effect these could have on women and girls across the United States. After hearing a broad overview, the afternoon concluded with two panels which honed in on specific impacts current and proposed policies will have. Lindsay Robinson of Planned Parenthood South Atlantic reminded...

Cervical cancer is an example of a glaring health disparity between wealthy and poor countries, and remains an immediate health threat to many women in low- and middle-income countries (LMICs). Evidence-based, cost-effective protocols recommended by the World Health Organization have not been widely implemented due to limited health care infrastructure augmented by a lack of funding and political will. Although there are some unique factors contributing to the disparity in cervical cancer outcomes between high and LMICs, there are some common root causes shared across health systems: poor health care infrastructure, lack of awareness of early signs or symptoms, lack of funding prioritization within local governments, and limited operationalization of proven technologies used in high-income countries. These root causes must be addressed through both innovation and adaptation of successful interventions to fit the target community and the priorities of local governments (i.e. be both low-cost and cost-effective). To achieve this, clinicians and researchers need to partner with policy experts and...